http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10212238-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bd433e19d43c4d9b2a68ed8443b9a9a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D339-06
filingDate 1997-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca44ffd9002d7e99944dcaee65bc85cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b500ca0d840033b1e30ca8a6a9674f56
publicationDate 1998-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H10212238-A
titleOfInvention Serum and cancer metastasis inhibitor
abstract (57) [Summary] General formula (I) (Wherein, R 1 represents an alkyl group having 1 to 6 carbon atoms; R 2 is an alkyl group having 1 to 10 carbon atoms, 3 carbon atoms A 5- to 6-membered heterocycle having 1 to 7 cycloalkyl groups or 1 to 3 identical or different hetero atoms selected from an oxygen atom, a sulfur atom or a nitrogen atom, The 6- to 6-membered heterocyclic ring can also have one or more substituents selected from the same or different halogen atoms or alkyl groups having 1 to 6 carbon atoms. A is -CH 2 CH 2 -, - CH = CH - , - CH 2 CH (OH) -, - C H (OH) CH (OH) -, or -CH 2 - indicates, X Represents -O- or -NH-. A serum obtained by administering the compound represented by the formula (1) to an animal, and a cancer metastasis inhibitor containing the serum as an active ingredient. The serum of the fraction having a molecular weight of 10,000 to 50,000 obtained by administering the compound represented by the general formula (I) has a cancer metastasis inhibitory action and is useful as a pharmaceutical.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0909758-A1
priorityDate 1996-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6946994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426124398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 27.